Key facts
- Notable investors include Harvard Innovation Launch Lab, LabCentral, Liquidmetal Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Alvus Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Alvus Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Alvus Health
Developer of an AI-based biotechnology model platform designed to transform biopharma and Medicare. The company's platform integrates with high-throughput automation, cell transfection for gene editing, and streamlines imaging data collection, enabling pharmaceutical companies and clinical researchers to conduct biotechnology research and reduce the cost and time required for drug discovery.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2022
- Website
- alvushealth.com/
- Ownership
- Privately Held (backing)
Alvus Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Alvus Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Alvus Health in its N-PORT filings yet. We sweep new filings monthly.